Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain
- PMID: 18378045
- DOI: 10.1016/j.neurobiolaging.2008.02.018
Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain
Abstract
Pathological accumulation of beta-amyloid peptide (Abeta) is an early and common feature of Alzheimer's disease (AD). An increased zinc concentration can initiate the deposition of Abeta. The present study aimed to study the expression and distribution patterns of six members of the zinc transporter (ZnT) family, ZnT1, ZnT3, ZnT4, ZnT5, ZnT6, and ZnT7, in the APPswe/PS1dE9 transgenic mouse brain. Our results demonstrated a statistically significant (P<0.05) increase of ZnT1, ZnT3, ZnT4, ZnT6, and ZnT7 in both hippocampus and neo-cortex using Western blot method and an abundant distribution of zinc ions in the plaques and amyloid angiopathic vessels using immersion autometallography. Furthermore, all ZnT immunoreactions were detected in most amyloid plaques and amyloid angiopathic vessels. ZnT1 and ZnT4 were extensively expressed in all parts of the plaques. ZnT3, ZnT5, and ZnT6 were expressed most prominently in the degenerating neurites in the peripheral part of the plaques, while ZnT7 was present in the core of the plaques. The amyloid angiopathic vessels showed a strong ZnT3 immunoreactivity. These results might suggest multiple roles of ZnTs in the deposition and organization of the Abeta composition.
Similar articles
-
Elevation of zinc transporter ZnT3 protein in the cerebellar cortex of the AbetaPP/PS1 transgenic mouse.J Alzheimers Dis. 2010;20(1):323-31. doi: 10.3233/JAD-2010-1363. J Alzheimers Dis. 2010. PMID: 20164588
-
Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain.Brain Res Bull. 2008 Sep 5;77(1):55-60. doi: 10.1016/j.brainresbull.2008.03.014. Epub 2008 Apr 18. Brain Res Bull. 2008. PMID: 18639746
-
Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.Neurobiol Dis. 2006 Sep;23(3):653-62. doi: 10.1016/j.nbd.2006.05.010. Epub 2006 Jul 10. Neurobiol Dis. 2006. PMID: 16829076
-
Cerebral amyloid angiopathy: pathogenetic mechanisms and link to dense amyloid plaques.Genes Brain Behav. 2008 Feb;7 Suppl 1:67-82. doi: 10.1111/j.1601-183X.2007.00380.x. Genes Brain Behav. 2008. PMID: 18184371 Review.
-
ZnT3: a zinc transporter active in several organs.Biometals. 2012 Feb;25(1):1-8. doi: 10.1007/s10534-011-9490-x. Epub 2011 Aug 25. Biometals. 2012. PMID: 21866305 Review.
Cited by
-
The Important Role of Zinc in Neurological Diseases.Biomolecules. 2022 Dec 23;13(1):28. doi: 10.3390/biom13010028. Biomolecules. 2022. PMID: 36671413 Free PMC article. Review.
-
Oxidative Stress Markers and Metal Ions are Correlated With Cognitive Function in Alzheimer's Disease.Am J Alzheimers Dis Other Demen. 2017 Sep;32(6):353-359. doi: 10.1177/1533317517709549. Epub 2017 May 29. Am J Alzheimers Dis Other Demen. 2017. PMID: 28554217 Free PMC article.
-
Clioquinol inhibits zinc-triggered caspase activation in the hippocampal CA1 region of a global ischemic gerbil model.PLoS One. 2010 Jul 29;5(7):e11888. doi: 10.1371/journal.pone.0011888. PLoS One. 2010. PMID: 20686690 Free PMC article.
-
Novel drug targets based on metallobiology of Alzheimer's disease.Expert Opin Ther Targets. 2010 Nov;14(11):1177-97. doi: 10.1517/14728222.2010.525352. Expert Opin Ther Targets. 2010. PMID: 20942746 Free PMC article. Review.
-
Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases.Mol Neurobiol. 2024 Dec;61(12):10747-10769. doi: 10.1007/s12035-024-04222-4. Epub 2024 May 23. Mol Neurobiol. 2024. PMID: 38780722 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
